We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

000591:SZSECECEP Solar Energy Co.,Ltd. Analysis

Data as of 2026-03-12 - not real-time

CN¥6.67

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

CECEP Solar Energy is trading at 6.67 CNY, comfortably above its 20‑day (5.86) and 50‑day (5.33) simple moving averages, and the bullish MACD (line above signal) reinforces a short‑term uptrend. However, the RSI of 74 signals an overbought condition and the price is flirting with the identified resistance around 6.80, suggesting a possible pull‑back. Volume is rising and volatility is high at nearly 49%, which can amplify price swings despite the stock’s low beta indicating limited systematic risk. On the fundamentals side, the stock’s trailing PE of 24.7 exceeds the industry average of 22.9, and the DCF‑derived fair value of 3.52 CNY is far below the market price, pointing to overvaluation. The company carries a heavy debt load (debt‑to‑equity ~99%) and negative free cash flow, while delivering a modest 1.79% dividend yield with a payout ratio of about 42%, raising questions about dividend sustainability. Nonetheless, operating margins are strong (>50%) and the renewable‑energy sector benefits from supportive policies, which could underpin longer‑term growth if balance‑sheet pressures are managed.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI at 74 indicating overbought conditions
  • Price approaching resistance near 6.80 CNY
  • Bullish MACD but high short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Forward PE of 14.5 suggests improved valuation
  • High debt‑to‑equity ratio limits financial flexibility
  • Stable dividend yield but negative free cash flow

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Long‑term policy support for renewable energy in China
  • Potential revenue growth from expanding solar assets
  • Dividend income offset by cash‑flow constraints

Key Metrics & Analysis

Financial Health

Revenue Growth-8.20%
Profit Margin19.75%
P/E Ratio24.7
ROE4.41%
ROA2.46%
Debt/Equity99.31
P/B Ratio1.1
Op. Cash FlowCN¥3.6B
Free Cash FlowCN¥-1320671744
Industry P/E22.9

Technical Analysis

TrendBullish
RSI74.1
SupportCN¥5.32
ResistanceCN¥6.80
MA 20CN¥5.86
MA 50CN¥5.33
MA 200CN¥4.75
MACDBullish
VolumeIncreasing
Fear & Greed Index75.48

Valuation

Fair ValueCN¥3.52
GradeOvervalued
TypeBlend
Dividend Yield1.79%

Risk Assessment

Beta0.11
Volatility48.91%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.